Interní Med. 2012; 14(6-7): 275-280

Interaction between vitamins and medicals

PharmDr.Miloslav Hronek, Ph.D., PharmDr.Miroslav Kovařík, Ph.D.
Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové

Vitamins together with medicals can create pharmacodynamics and pharmacokinetics interactions that involve in plasmatic levels of

vitamins. The article is summary of recent known interactions, applicable in practice.

Keywords: interaction, medical, vitamin

Published: July 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hronek M, Kovařík M. Interaction between vitamins and medicals. Interní Med. 2012;14(6-7):275-280.
Download citation

References

  1. Tatro DS, et al. Drug interaction facts. St. Louis: Facts Comparisons A Wolters Kluwer Company, 2001: 1424.
  2. Stockley's Drug Interactions Pocket Companion 2010, edited by Karen Baxter, Pharmaceutical Press, Londýn, 2010: 495.
  3. Suchopár J, et al. Kompendium lékových interakcí. Infopharm 2005. Infopharm, 2004, 2048.
  4. Databáze Micromedex 2.0.
  5. Hronek M. Výživa ženy v obdobích těhotenství a kojení. Praha: Maxdorf (edice Jessenius), 2004: 309.
  6. Mastroiacovo P, Mazzone T, Addis A. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology 1999; 59: 7-11. Go to original source... Go to PubMed...
  7. Moskowitz Y, Leibowitz E, Ronen M, et al. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol 1993; 25: 306-308.
  8. West KP, Katz J, Khatry SK et al. Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. Brit Med J 1999; 318: 570-575. Go to original source... Go to PubMed...
  9. Cooke HM. Lovastatin- and niacin-induced rhabdomyolysis. Hosp Pharm 1994; 29: 33-34.
  10. Vacek JL, Dittmeier G, Chiarelli T, et al. Comparison of lovastatin (20mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoproteinemia. Am J Cardiol 1995; 76: 182-184. Go to original source... Go to PubMed...
  11. Smith HT, Jokubaitis LA, Troendle AJ, et al. Pharmacokinetics of fluvastatin and specific drug interactions. Am J Hypertens 1993; 6: 375S-382S. Go to original source... Go to PubMed...
  12. Christopher A. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose. Ann Pharmacother Nov, 2011; 45(11): e58. Go to original source... Go to PubMed...
  13. Rockwell KA. Potential interaction between niacin and transdermal nicotine (letter). Ann Pharmacother 1993; 27: 1283-1284. Go to original source... Go to PubMed...
  14. Marcuard S, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med 1994; 120: 211-215. Go to original source... Go to PubMed...
  15. Yahr MD, Duvoisin RC. Pyridoxine, levodopa and l-?-methyldopa hydrazine regimen in parkinsonism. JAMA 1971; 216: 2141. Go to original source...
  16. Van Delden C, Hirschel B. Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcomes. J Infect Dis 1996; 173: 1294-1295. Go to original source... Go to PubMed...
  17. Domingo JL, Gomez M, Llobet JM, et al. Effect of ascorbic acid on gastrointestinal aluminum absorption (letter). Lancet 1991; 338: 1467. Go to original source... Go to PubMed...
  18. McDuffie JR, Calis KA, Booth SL, et al. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002; 22(7): 814-822. Go to original source... Go to PubMed...
  19. Corrigan JJ, Ulfers LL. Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency. Am J Clin Nutr 1981; 34: 1701-1705. Go to original source... Go to PubMed...
  20. Harrell CC, Kline SS. Vitamin K-supplemented snacks containing olestra: implications for patients taking warfarin. JAMA 1999; 282(12): 1133-1134. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.